BIVDA Chief Executive Doris-Ann Williams has commented on the launch of the Medicines and Diagnostic Manufacturing Transformation Fund.

“We welcome the announcement of the Medicines and Diagnostic Manufacturing Transformation Fund by the Prime Minister today.

The lessons the country has learned during this difficult year in pandemic response must not be forgotten, and the innovations should be used to improve our diagnostic testing system for non-COVID illnesses including cancer, hepatitis and diabetes, to name but a few.

Last week we wrote to the Prime Minister on behalf of BIVDA members outlining the critical role they have played in scaling up our testing capacity, and we hope that Mr Johnson will recognise the need to involve British in-vitro diagnostic companies in the implementation of this fund.”

ENDS

For more information please contact BIVDA External Affairs Manager Jon Harrison jonh@bivda.org.uk